95390 ⎘
Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both; Sulfur atom attached in position 6
PARP INHIBITORS FOR TREATING CANCER AND ASTHMA
#2NOVEL KINASE MODULATORS
#3THIOPURINE-BASED COMPOUND, COMPOSITION, METHOD OF PREPARATION AND APPLICATIONS
#4PARP inhibitors for treating cancer and asthma
#5Kinase modulators
#6Electroplating composition and electroplating method
#7Inhibitors of human phosphatidylinositol 3-kinase delta
#8ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
#9Medicament for liver regeneration and for treatment of liver failure
#10MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE
#116-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
#12Mercaptopurine hemihydrate
#13Inhibitors of human phosphatidylinositol 3-kinase delta
#14Inhibitors of human phosphatidylinositol 3-kinase delta
#15Inhibitors of PI3K-delta and methods of their use and manufacture
#166-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
#17Alternative nucleic acid molecules and uses thereof
#1812-epi pleuromutilins
#19Kinase modulators
#20Medicament for liver regeneration and for treatment of liver failure
#21Purine inhibitors of human phosphatidylinositol 3-kinase delta
#22Kinase modulators
#23Isochromene derivatives as phoshoinositide 3-kinases inhibitors
#24Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
#25Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
#26Inhibitors of human phosphatidylinositol 3-kinase delta
#27Immune system modulators
#28Inhibitors of PI3K-delta and methods of their use and manufacture
#296-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
#30Inhibitors of human phosphatidylinositol 3-kinase delta
#31Acid-labile trigger units
#32Inhibitors of human phosphatidylinositol 3-kinase delta
#33Heterocyclic compounds and their uses
#344H-chromen-4-one compounds as modulators of protein kinases
#35ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
#362,3-disubstituted chromen-4-one compounds as modulators of protein kinases
#37Inhibitors of human phosphatidylinositol 3-kinase delta
#38Inhibitors of human phosphatidylinositol 3-kinase delta
#396-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
#40Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
#41Aryl carbonyl derivatives as therapeutic agents
#42Aryl carbonyl derivatives as therapeutic agents
#43Metal coordinated compositions
#44Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
#45Arylsulfonylnaphthalene derivatives as 5HTantagonists
#46Bioreductively-activated prodrugs
#47Thionucleoside-S-nitrosyl derivative
#48Aryl carbonyl derivatives as therapeutic agents
#49Substituted alcohols useful in treatment of Alzheimer's disease
#50Inhibitors of human phosphatidylinositol 3-kinase delta
#51AN IMPROVED PROCESS FOR THE PREPARATION OF PURINES
#52Analogs of nitrobenzylthioinosine